Isovue-M

Adult Dosing .

Dosage forms:  INJ: 200 mg per mL, 300 mg per mL

Special Note

[strength clarification]

Info: strength expressed as iodine concentration

[equivalency or interchangeability info]

Info: intrathecal iopamidol not interchangeable with other iopamidol products; do not substitute on a mg to mg basis

computed tomography cisternography

[4-6 mL (200 mg per mL) intrathecally x1]

myelography

[lumbar]

Dose: 10-15 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[thoracic]

Dose: 10-15 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[cervical, via lumbar injection]

Dose: 10-15 mL (200 mg per mL) intrathecally x1; Alt: 10 mL (300 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[cervical, via lateral cervical injection]

Dose: 10 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[total columnar]

Dose: 10 mL (300 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

renal dosing

[see below]

renal impairment: not defined, caution advised

HD/PD: not defined

hepatic dosing

[see below]

hepatic impairment: not defined, caution advised in hepatorenal disease

Peds Dosing .

Dosage forms:  INJ: 200 mg per mL, 300 mg per mL

Special Note

[strength clarification]

Info: strength expressed as iodine concentration

[equivalency or interchangeability info]

Info: intrathecal iopamidol not interchangeable with other iopamidol products; do not substitute on a mg to mg basis

myelography

[lumbar, 2-7 yo]

Dose: 7-9 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[lumbar, 8-12 yo]

Dose: 8-11 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[lumbar, 13 yo and older]

Dose: 10-12 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[thoracic, 2-7 yo]

Dose: 7-9 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[thoracic, 8-12 yo]

Dose: 8-11 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

[thoracic, 13 yo and older]

Dose: 10-12 mL (200 mg per mL) intrathecally x1; Info: may readminister no sooner than 48h after initial dose

renal dosing

[see below]

renal impairment: not defined, caution advised

HD/PD: not defined

hepatic dosing

[see below]

hepatic impairment: not defined, caution advised in hepatorenal disease